QUINTESSENTIAL-2

Phase 3 Clinical Trial Comparing the Safety and Efficacy of BMS-986393 to Standard of Care Regimens in Patients with Relapsed/Refractory Multiple Myeloma

Near Add Your Location

Sorting 7 by

UCLA Medical Center, Santa Monica
UCLA Health
Santa Monica, CA
  • Accepting patients
Winship Cancer Institute
Emory University
Atlanta, GA
  • Accepting patients
Get personalized results in 60 seconds
All clinical trials have eligibility criteria - or a list of reasons why you may be able or unable to participate in a trial. Answer a few questions to view your personalized results - all in under 60 seconds.
Help me find trials
Fox Chase Cancer Center
Temple Health
Philadelphia, PA
  • Accepting patients
Huntsman Cancer Institute
University of Utah
Salt Lake City, UT
  • Not yet accepting
University of Alabama at Birmingham
O'Neal Comprehensive Cancer Center
Birmingham, AL
  • Not yet accepting
Sylvester Comprehensive Cancer Center (Main)
University of Miami Health System
Miami, FL
  • Not yet accepting
Cleveland Clinic - Taussig Cancer Center
Taussig Cancer Institute
Cleveland, OH
  • Not yet accepting
5 hidden based on your filters. Show All

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print this trial to share with your doctor.

(888) 828-2206

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.